Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Inositol Phosphate Signaling Regulates Natural Killer Cell Development and Function

By LabMedica International staff writers
Posted on 13 Dec 2012
A team of immunobiologists has identified the phosphorylated IP3 (inositol trisphosphate) metabolite inositol(1,3,4,5)tetrakisphosphate (IP4) as an important novel regulator of NK (natural killer) cell development and function.

NK cells are large granular lymphocytes (LGL) that constitute the third kind of cells differentiated from the common lymphoid progenitor generating B and T lymphocytes. More...
NK cells are known to differentiate and mature in the bone marrow, lymph node, spleen, tonsils, and thymus where they then enter into the circulation.

Investigators at The Scripps Research Institute (La Jolla, CA, USA) worked with a line of mice that had been genetically engineered to lack the gene coding for the enzyme inositol-trisphosphate 3-kinase B (ItpkB), which regulates inositol phosphate metabolism by phosphorylation of second messenger IP3 to IP4. The activity of this enzyme is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Itpkb regulates immune cell function and is required for T and B cell development.

In a paper published in the November 21, 2012, online edition of the journal Blood, the investigators identified a novel role for IP4 in NK cells. IP4 promoted NK cell terminal differentiation and acquisition of a mature NKR (NK receptor) repertoire. However, in mature NK cells, IP4 limited NKR induced IFNgamma (interferon gamma) secretion, granule exocytosis, and target-cell killing, in part by inhibiting the PIP3 effector-kinase Akt. The enzyme PIP3 activates downstream signaling components, the most notable one being the protein kinase AKT, which in turn activates downstream anabolic signaling pathways required for cell growth and survival.

“This is an exciting finding because it could possibly lead to the development of drugs that improve Natural Killer cell function,” said first author Dr. Karsten Sauer, associate professor of immunology and microbial science at The Scripps Research Institute. “Natural Killer cells have gained clinical interest as innovative biological therapeutics for certain cancers and also in certain infectious diseases.”

“The enzyme ItpkB has unique features that facilitate its highly specific inhibition by small molecules,” said Dr. Sauer. "Our findings suggest that such compounds could possibly be used to improve Natural Killer cell function therapeutically.”

Related Links:
The Scripps Research Institute



Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.